Planning for avian influenza

Annals of Internal Medicine

Volumn 145, Issue 2, 2006, Pages 141-144

  Bartlett, John G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; AVIAN INFLUENZA VACCINE; OSELTAMIVIR; SIALIDASE INHIBITOR; ZANAMIVIR; SIALIDASE;

AVIAN INFLUENZA; BIOLOGICAL WARFARE; CLINICAL FEATURE; DISASTER; DISEASE TRANSMISSION; DOSE RESPONSE; DRUG EFFICACY; EPIDEMIC; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HUMAN; INFLUENZA VIRUS A H5N1; MORTALITY; PANDEMIC; POULTRY; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK ASSESSMENT; SPANISH INFLUENZA; ARTICLE; DRUG ANTAGONISM; HOSPITAL PLANNING; INFLUENZA; PATIENT CARE; RISK FACTOR; UNITED STATES;

ANTIVIRAL AGENTS; DISEASE OUTBREAKS; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; HEALTH PERSONNEL; HEALTH PLANNING; HOSPITAL PLANNING; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; NEURAMINIDASE; PATIENT ISOLATION; RISK FACTORS; UNITED STATES;

EID: 33746730567     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-145-2-200607180-00133     Document Type: Review

References (24)

1. Webster RG, Peiris M, Chen H, Guan Y. H5N1 outbreaks and enzootic influenza. Emerg Infect Dis. 2006;12:3-8.
2. Belshe RB. The origins of pandemic influenza - lessons from the 1918 virus. N Engl J Med. 2005;353:2209-11.
3. Starr I. Influenza in 1918: recollections of the epidemic in Philadelphia. Ann Intern Med. 2006;145:138-40.
4. Tran TH, Nguyen TL, Nguyen TD, Luong TS, Pham PM, Nguyen VC, et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med. 2004;350:1179-88.
5. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med. 2005;353:1374-85.
6. Taubenberger JK, Reid AH, Lourens RM, Wang R, Jin G, Fanning TG. Characterization of the 1918 influenza virus polymerase genes. Nature 2005;437:794-5.
7. Tumpey TM, Basler CF, Aguilar PV, Zeng H, Solorzano A, Swayne DE, et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science. 2005;310:77-80.
8. American College of Physicians. The health care response to pandemic influenza. Ann Intern Med. 2006;145:135-7.
9. Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med. 2006;354:1343-51.
10. Poland GA. Vaccines against avian influenza - a race against time [Editorial]. N Engl J Med. 2006;354:1411-3.
11. Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med. 2005;353:1363-73.
12. de Jong MD, Tran TT, Truong HK, Vo MH, Smith GJ, Nguyen VC, et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med. 2005;353:2667-72.
13. Hayden F, Klimov A, Tashiro M, Hay A, Monto A, McKimm-Breschkin J, et al. Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A/H5N1 viruses. Antivir Ther. 2005;10:873-7.
14. Ferguson NM, Cummings DA, Fraser C, Cajka JC, Cooley PC, Burke DS. Strategies for mitigating an influenza pandemic. Nature. 2006.
15. Marghella PD. Surge capacity planning in healthcare organizations: hitting the mark on enhancing national preparedness. Homeland Defense Journal. 2005:2. Accessed at www.homelanddefensejournal.com/pdfs/Medical_Stories/ SurgePlanning_Marghella_Sept05.pdf on 6 June 2006.
16. Inglesby T. Senate Subcommittee on Bioterrorism and Public Health Preparedness Roundtable on All Hazards Medical Preparedness and Response. 5 April 2006. Accessed at www.upmc-biosecurity.org/pages/resources/hearings /060405-tvi-allhazardsmedprep.pdf on 9 June 2006.
17. Toner E, Waldhorn R, Maldin B, Borio L, Nuzzo JB, Lam C, et al. Hospital preparedness for pandemic influenza. Biosecurity and Bioterrorism: Bio-defense Strategy, Practice, and Science. 2006;4:1-11.
18. Homeland Security Council. National Strategy for Pandemic Influenza Implementation Plan. May 2006. Accessed at www.whitehouse.gov/homeland/ nspi_implementation.pdf on 9 June 2006.
19. Blank S, Moskin LC, Zucker JR. An ounce of prevention is a ton of work: mass antibiotic prophylaxis for anthrax, New York City, 2001. Emerg Infect Dis. 2003;9:615-22.
20. Clark CC. In harm's way: AMA physicians and the duty to treat. J Med Philos. 2005;30:65-87.
21. Masur H, Emanuel E, Lane HC. Severe acute respiratory syndrome: providing care in the face of uncertainty [Editorial]. JAMA. 2003;289:2861-3.
22. Koh D, Lim MK, Chia SE, Ko SM, Qian F, Ng V, et al. Risk perception and impact of Severe Acute Respiratory Syndrome (SARS) on work and personal lives of healthcare workers in Singapore: what can we learn? Med Care. 2005;43:676-82.
23. Bournes DA, Ferguson-Pare M. Persevering through a difficult time during the SARS outbreak in Toronto. Nurs Sci Q. 2005;18:324-33.
24. Mounier-Jack S, Coker RJ. How prepared is Europe for pandemic influenza? Analysis of national plans. Lancet. 2006;367:1405-11.